Strides Pharma Science Ltd (STAR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 688428, "name": "Strides Pharma", "stock_name": "Strides Pharma", "full_name": "Strides Pharma Science Ltd", "name_url": "stocks-analysis/strides-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,110.90", "chg": 0.1, "chgp": "0.01%", "dir": 1, "prev_price": "1,110.80", "mcapval": "10,324.00 Cr", "mcap": "Small Cap", "scripcode": 532531, "symbol": "STAR", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE939A01011", "curr_date": "Jun 19, 03:30 PM", "curr_time": "23:04 PM", "last_traded_at": "Jun 19, 03:30 PM IST", "bse_nse_vol": "71.41 k", "exc_status": "Active", "traded_date": "Jun 19, 2026", "traded_date_str": "2026 06 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MN", "url": "https://www.marketsmojo.com/mojopro/strategy/2", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/strides-pharma-688428-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Strides Pharma Science Ltd Shows Bullish Momentum Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-shows-bullish-momentum-amid-mixed-technical-signals-4058138", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/StridesPharmaSc_technicaldot_4058138.png", "date": "2026-06-17 08:03:38", "description": "Strides Pharma Science Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by strong weekly and monthly MACD indicators and daily moving averages. Despite some bearish signals from monthly RSI and KST, the stock’s recent performance and technical parameters suggest a cautiously optimistic outlook for investors." }, { "title": "Strides Pharma Gains 1.09%: Valuation Shift and Intraday Surge Drive Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-gains-109-valuation-shift-and-intraday-surge-drive-momentum-4051336", "imagepath": "", "date": "2026-06-13 12:09:12", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>8 June:</strong> Stock opens at Rs.1,005.20, down 3.62% amid broad market weakness</p>\n <p><strong>11 June:</strong> Valuation shifts to very attractive despite price dip to Rs.977.95</p>\n <p><strong>12 June:</strong> Intraday high of Rs.1,062.90 with a 7.14% surge closing at Rs.1,054.30</p>\n <p><strong>12 June:</strong> Week closes at Rs.1,054.30, up 1.09% for the week versus Sensex +0.57%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\">\n <div class=\"stat-label\">Week Open</div>\n <div class=\"stat-value\">Rs.1,042.95</d..." }, { "title": "Strides Pharma Science Ltd Surges 7.14% to Day's High of Rs 1062.9 — Outperforms Sector by 6.32 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-hits-intraday-high-with-714-surge-on-12-june-2026-4049293", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/StridesPharmaSc_priceRelatedfactors_4049293.png", "date": "2026-06-12 15:33:21", "description": "The Sensex climbed 2.3% on 12 Jun 2026, yet Strides Pharma Science Ltd outpaced the broader market with a 7.14% gain, reaching an intraday high of Rs 1062.9. This 6.32 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind." }, { "title": "Strides Pharma Science Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-hold-4048988", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/StridesPharmaSc_mojoScore_4048988.png", "date": "2026-06-12 10:10:05", "description": "Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Strides Pharma Science Ltd Valuation Shifts to Very Attractive Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-valuation-shifts-to-very-attractive-amid-market-volatility-4045734", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/StridesPharmaSc_valuationdot_4045734.png", "date": "2026-06-11 08:00:53", "description": "Strides Pharma Science Ltd has seen a marked improvement in its valuation metrics, shifting from an attractive to a very attractive rating, even as the broader pharmaceuticals sector faces headwinds. With a current price-to-earnings (P/E) ratio of 15.56 and a price-to-book value (P/BV) of 2.90, the company stands out favourably against its peers, signalling a potential opportunity for investors seeking value in a challenging market environment." }, { "title": "Strides Pharma Science Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-signal-bullish-outlook-4032883", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/StridesPharmaSc_technicaldot_4032883.png", "date": "2026-06-03 08:03:32", "description": "Strides Pharma Science Ltd has recently exhibited a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Despite a day’s decline of 1.73%, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, suggesting a nuanced outlook for investors in this small-cap pharmaceutical player." }, { "title": "Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4029563", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/StridesPharmaSc_technicaldot_4029563.png", "date": "2026-06-02 08:05:53", "description": "Strides Pharma Science Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early June 2026. While key weekly and monthly indicators such as MACD remain positive, bearish signals from RSI and mixed readings from other oscillators suggest a complex near-term outlook for this small-cap pharmaceutical player." }, { "title": "Strides Pharma Science Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/strides-pharma-science-ltd-is-rated-hold-4026299", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/StridesPharmaSc_mojoScore_4026299.png", "date": "2026-06-01 10:10:04", "description": "Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Strides Pharma Science Ltd’s Volatile Week: -0.08% Price Change Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/strides-pharma-science-ltds-volatile-week--008-price-change-amid-mixed-signals-4008603", "imagepath": "", "date": "2026-05-23 16:05:20", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>18 May:</strong> Q4 FY26 results reveal strong profit growth amid margin concerns</p>\n <p><strong>19 May:</strong> Intraday low hit at Rs.1,045.8 amid heavy price pressure despite positive market</p>\n <p><strong>19 May:</strong> Positive quarterly performance reported with 27.1% PAT growth</p>\n <p><strong>22 May:</strong> Week closes at Rs.1,153.05, down 0.08% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\">\n <div class=\"stat-label\">Week Open</div>\n <div class=\"stat-value\">Rs.1,154.00</div>\n ..." } ], "total": 698, "sid": "688428", "stock_news_url": "https://www.marketsmojo.com/news/strides-pharma-science-688428" }, "announcements": [ { "details": "Strides Pharma Science Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Strides Pharma Science Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "05-Dec-2019" }, { "details": "Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.", "source": "NSE", "caption": "Strides Pharma Science Limited - Shareholders meeting", "datetime": "26-Nov-2019" }, { "details": "Strides Pharma Science Limited has informed the Exchange regarding a press release dated November 08, 2019, titled \"Strides announces relaunch of Ranitidine tablets (Rx) for the US Market\".", "source": "NSE", "caption": "Strides Pharma Science Limited - Press Release", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Strides Pharma Science Ltd has declared <strong>40%</strong> dividend, ex-date: 22 Jul 25", "dt": "2025-07-22", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

8 June: Stock opens at Rs.1,005.20, down 3.62% amid broad market weakness

11 June: Valuation shifts to very attractive despite price dip to Rs.977.95

12 June: Intraday high of Rs.1,062.90 with a 7.14% surge closing at Rs.1,054.30

12 June: Week closes at Rs.1,054.30, up 1.09% for the week versus Sensex +0.57%

Week Open

Rs.1,042.95Read full news article

Strides Pharma Science Ltd Surges 7.14% to Day's High of Rs 1062.9 — Outperforms Sector by 6.32 Percentage Points

2026-06-12 15:33:21

The Sensex climbed 2.3% on 12 Jun 2026, yet Strides Pharma Science Ltd outpaced the broader market with a 7.14% gain, reaching an intraday high of Rs 1062.9. This 6.32 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.

Read full news article

Strides Pharma Science Ltd is Rated Hold

2026-06-12 10:10:05

Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Strides Pharma Science Ltd Valuation Shifts to Very Attractive Amid Market Volatility

2026-06-11 08:00:53

Strides Pharma Science Ltd has seen a marked improvement in its valuation metrics, shifting from an attractive to a very attractive rating, even as the broader pharmaceuticals sector faces headwinds. With a current price-to-earnings (P/E) ratio of 15.56 and a price-to-book value (P/BV) of 2.90, the company stands out favourably against its peers, signalling a potential opportunity for investors seeking value in a challenging market environment.

Read full news article

Strides Pharma Science Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-06-03 08:03:32

Strides Pharma Science Ltd has recently exhibited a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. Despite a day’s decline of 1.73%, the stock’s technical indicators reveal a complex interplay of bullish and bearish signals, suggesting a nuanced outlook for investors in this small-cap pharmaceutical player.

Read full news article

Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-02 08:05:53

Strides Pharma Science Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early June 2026. While key weekly and monthly indicators such as MACD remain positive, bearish signals from RSI and mixed readings from other oscillators suggest a complex near-term outlook for this small-cap pharmaceutical player.

Read full news article

Strides Pharma Science Ltd is Rated Hold

2026-06-01 10:10:04

Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.